Biophotonics
Data on biophotonics detailed by researchers at City of Hope National Medical Center
Published in Blood Weekly, November 15th, 2007
New research, 'Medulloblastomas expressing IL13Ralpha2 are targets for IL13-zetakine+ cytolytic T cells,' is the subject of a report. According to recent research from the United States, "Central nervous system loco-regional disease relapse is a common etiology of treatment failure for medulloblastoma (MB)/primitive neuroectodermal tumors. Therapeutic targeting of primary disease and the adjacent craniospinal cerebral spinal fluid pathways should decrease relapse rates and allow for the curtailed use of radiation therapy."
"The adoptive transfer of tumor-specific cytolytic T cells (CTLs) to the tumor bed and cerebral spinal fluid is an attractive strategy, but limited...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-11-15)
More Articles from Blood Weekly
- Acute Pancreatitis
Is it pancreatitis in acute abdominal pain in acute viral hepatitis? - Biosafety
Agencies must win trust of locals to contain Marburg and Ebola outbreaks - Bioterrorism
Specialists in infectious disease and global health convene at Philadelphia meeting - Borne Disease
Fine-tuning lasers to destroy blood-borne diseases like AIDS - Coagulation
Early predictive model may be new 'weapon' against leading cause of death on battlefield - Acute Promyelocytic Leukemia
New acute promyelocytic leukemia study findings recently were published by H. Yoshida and co-researchers - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
